Current State of Management of Severe Pre-Eclampsia and Eclampsia using Magnesium Sulphate in Different Health Facilities of Mid-Western Development Regions
According to the Nepal Maternal Mortality and Morbidity Study (2009), pre-eclampsia/eclampsia is the second leading cause of maternal mortality in Nepal—accounting for 21% of all maternal deaths. For management of severe pre-eclampsia and eclampsia (SPE/E), WHO has identified magnesium sulphate as...
Wedi'i Gadw mewn:
Prif Awdur: | Chalise, Gital Dhakal |
---|---|
Fformat: | Technical Report |
Iaith: | en_US |
Cyhoeddwyd: |
2012
|
Pynciau: | |
Mynediad Ar-lein: | http://103.69.126.140:8080/handle/123456789/571 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Current State of Management of Severe Pre-Eclampsia and Eclampsia using Magnesium Sulphate in Different Health Facilities of Mid Western Development Region
gan: Chalise Dhakal, G
Cyhoeddwyd: (2016) -
Effect of Magnesium Sulphate in Eclampsia at maternity hospital
gan: Verma, Dr. Sheela
Cyhoeddwyd: (2013) -
Current state of management of severe pre-eclampsia and eclampsia using magnesium sulphate in Different health facilities of mid western development region
gan: Chalise, Gita Dhakal
Cyhoeddwyd: (2010) -
Effect of magnesium sulfate in eclampsia at maternity hospital
gan: Verma, Sheela
Cyhoeddwyd: (2003) -
Pre-test of adolescent sexual and reproductive health newsletter -III
gan: Center for Research on Environment Health and Population Activities (CREHPA)
Cyhoeddwyd: (2013)